Synapse - Ferrata Storti Foundation

Results (357)

Efficacy and safety of defibrotide to treat hepatic veno-occlusive disease/sinusoidal obstruction syndrome post-chemotherapy: A post hoc analysis of final data of an expanded-access protocol

Meeting Abstract

Kernan, N.; Richardson, P.; Grupp, S.; Antin, J.; Messinger, Y.; Liang, W.; Ryan, R.; Hume, R.; Tappe, W.; Soiffer, R.
Haematologica (2017)

Fulltext@MSK | Save

Analysis of dasatinib and imatinib 5-year efficacy and safety based on baseline comorbidity and age in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) in DASISION

Meeting Abstract

Saglio, G.; Cortes, J. E.; Hochhaus, A.; Shah, N. P.; Atallah, E. L.; Abaskharoun, M.; Li, L.; Mauro, M. J.
Haematologica (2017)

Fulltext@MSK | Save

Case-based learning in continuing education: Improving hematologist/oncologist evidence-based decisions for preventing Hogdkin lymphoma post-transplant relapse

Meeting Abstract

Repetto, P.; Moskowitz, C.
Haematologica (2017)

Fulltext@MSK | Save

Analysis of the genomic landscape of multiple myeloma highlights novel candidate prognostic markers and disease subgroups

Meeting Abstract

Bolli, N.; Biancon, G.; Moarii, M.; Gimondi, S.; Li, Y.; De Philippis, C.; Maura, F.; Sathiaseelan, V.; Yu-Tzu, T.; Mudie, L.; more...
Haematologica (2017)

Fulltext@MSK | Save

WT1 heteroclitic epitope immunization following autologous stem cell transplantation in patients with high-risk multiple myeloma (MM)

Meeting Abstract

Koehne, G.; Devlin, S.; Chung, D.; Landau, H.; Korde, N.; Mailankody, S.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Giralt, S.; more...
Haematologica (2017)

Fulltext@MSK | Save

Durable long-term survival of adult patients with B-ALL after CD19 CAR (19-28z) T cell therapy

Meeting Abstract

Park, J.; Riviere, I.; Wang, X.; Senechal, B.; Wang, Y.; Purdon, T.; Brentjens, R.; Sadelain, M.
Haematologica (2017)

Fulltext@MSK | Save

Variant FLT3 mutations can be eradicated by cytarabine/anthracycline/crenolanib induction in adult patients with newly diagnosed FLT3 (ITK/TKD) mutant AML

Meeting Abstract

Wang, E.; Stone, R.; Collins, R.; Agrawal, T.; Urity, V.; Tallman, M.
Haematologica (2017)

Fulltext@MSK | Save

Patients with acute myeloid leukemia who have mutations in IDH1 or IDH2 respond well to induction chemotherapy with "7+3" despite the presence of complex karyotype or FLT3-ITD

Meeting Abstract

Gupta, D. M.; Devlin, D. S.; Tallman, D. M.; Stein, D. E.
Haematologica (2017)

Fulltext@MSK | Save

Venetoclax (VEN) in patients with relapsed/refractory non-Hodgkin lymphoma (NHL)

Meeting Abstract

Davids, M. S.; Roberts, A. W.; Seymour, J. F.; Wierda, W. G.; Puvvada, S. D.; Gressick, L.; Alter, D.; Zhou, L.; Kim, S. Y.; Verdugo, M.; more...
Haematologica (2017)

Fulltext@MSK | Save

Phase 3 ALCANZA study of brentuximab vedotin (BV) or physician's choice (PC) of methotrexate (MTX) or bexarotene (Bex) in CD30-positive cutaneous T-cell lymphoma (CTCL): Number needed to treat analysis

Meeting Abstract

Zagadailov, E.; Prince, H. M.; Whittaker, S.; Horwitz, S.; Duvic, M.; Kim, Y.; Dummer, R.; Scarisbrick, J.; Quaglino, P.; Zinzani, P. L.; more...
Haematologica (2017)

Fulltext@MSK | Save

Ferrata Storti Foundation

People

Groups

Results (357)

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Ferrata Storti Foundation – authorized name for: